Breaking News, Promotions & Moves

Harmony Labs

Dr. Charles Gray has been appointed vice president of R&D at Harmony Labs.

Dr. Charles Gray has been appointed vice president of R&D at Harmony Labs. Dr. Gray will lead the formulation and analytical teams in the support of Harmony’s Rx, OTC, Animal Health and Cosmetic market segments. Dr. Gray most recently served as executive director for product development at GlaxoSmithKline/Stiefel Laboratories. Dr. Gray also served as director of regulatory affairs at Stiefel Laboratories.

Dr. Gray succeeds John Maloney, who has been appointed vice president of Rx product and process development. Dr. Maloney has expertise in drug development, process scale-up and on-going production support. He will work to advance Harmony’s Rx product development, technical and analytical services, and manufacturing offerings. Prior to joining the company four years ago, Dr. Maloney held R&D leadership positions at Taro Pharmaceuticals and Alpharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters